Company Overview - MicroPort NeuroTech is a leading company in China's neuro-interventional medical device industry, recognized as the largest in the country, providing innovative solutions to doctors and patients [3] - Since the approval of its first product in 2004, the company has developed a portfolio of 30 commercialized products and candidates [3] Financial Performance - As of December 31, 2024, MicroPort NeuroTech achieved total revenue of 762 million yuan, representing a year-on-year growth of 14.44% [2] - The net profit attributable to shareholders was 254 million yuan, showing a significant increase of 74.63% year-on-year [2] - The gross margin stood at 72.98%, with a debt-to-asset ratio of 16.44% [2] Stock Performance - On June 3, the stock price of MicroPort NeuroTech closed at 12.26 HKD per share, marking an increase of 19.96% with a trading volume of 44.0165 million shares and a turnover of 513 million HKD [1] - Over the past month, the stock has experienced a cumulative decline of 6.41%, but it has risen by 18.7% year-to-date, outperforming the Hang Seng Index's increase of 15.44% [2] Industry Valuation - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -22.3 times, with a median of 0.29 times [3] - MicroPort NeuroTech's P/E ratio is 21.43 times, ranking 31st in the industry [3] - Comparatively, other companies in the sector have significantly lower P/E ratios, such as Giant Medical Holdings at 0.2 times and Jingjiu Health at 0.38 times [3]